Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 812-241-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Cohesium was tested for eye irritation by an alternative method (application to fibroblast of rabbit cornea by the neutral red release method). The substance has not important cytotoxicity.
OF14 AT was tested for cytotoxicity in a GLP study, and the IC50 resulted to be 102.75 mg/mL.
OF14 AT was found to be non-irritant for skin in a GLP study conducted according to OECD 439.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- September 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes
- Test system:
- human skin model
- Remarks:
- human reconstructed epidermis (tissues)
- Cell type:
- other: human reconstructed epidermis (tissues)
- Cell source:
- other: SkinEthic Laboratories
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- SkinEthicTM RHE
Description: SKINETHIC RhE: RECONSTRUCTED HUMAN EPIDERMIS, 0.5cm² reconstructed epidermal human keratinocutes. Cells are grown on inert polycarbonate filter on chemically defined medium, airlifted for 17 days, till a highly differentiated and stratified epidermis model is obtained comprising the main basal, supra basa, spinous and granular layers and a functional stratum corneum. The RHE model presents a histological morphology comparable to the in vivo human tissue. - Type of coverage:
- other: not applicable
- Preparation of test site:
- other: not applicable
- Vehicle:
- other: not applicable
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 10 µL of sterile water and 16 +/-2 mg of the test item was applied to the epidermis surface.
CONTROLS
- Negative control:16 +/- 0.5 μL of Dulbecco’s Phosphate-Buffered Saline (D-PBS)
- Positive control: 16 +/- 0.5 μL of 5 % (w/v) aqueous solution of Sodium Dodecyl Sulfate (SDS) - Duration of treatment / exposure:
- Triplicate tissues were treated with the test item for an exposure period of 42 +/- 1 minutes at room temperature.
At the end of the exposure period, tissues were rinsed and incubated at 37 °C, 5 % CO2 in a humidified incubator for 42 h. - Number of animals:
- Triplicate tissues for test item, negative and positive controls
- Details on study design:
- PRE-INCUBATION STEP
After arrival, 9 RHE will be transferred into new 6-well plates with 1 mL/well of roome temperature SkinEthic Growth Medium (SGM). The absence of air bubbles will be checked by observing underneath the well of the plate. The plate will be then incubated from 1 hour and 30 minutes to 24 hours at 37°C +/- 1°C, 5+/-1% CO2.
PREPARATION OF TEST SOLUTIONS:
32 mg/cm² of test substance will be used
16 +/- 2 mg of test substance, will be applied to each insert, in triplicate.
Positve control: 5% SDS in sterile water
Negative control: DPBS
TREATMENT OF TISSUES
Before starting the test, RHE inserts will be transferred into a new 24- well plate, supplemented with 300µL of fresh SkinEthic Maintenance Medium (SMM) in each well.
10µL of sterile water and 16+/-2mg of solid test substance will be applied in the center of the insert in triplicate.
For negative and positive controls, 16 +/- 0.5 µL will be applied in triplicate.
The exposure of the tissues to the test and control items was performed at room temperature for 42 minutes (± 1 minute).
RINSING OF TISSUES AND INCUBATION FOR 42 HOURS
At the end of the treatment period, each tissue was removed from the well of the treatment plate, and rinsed with D-PBS to remove any residual test or control items. The rinsed tissues were incubated at 37 °C, 5 % CO2 in a humidified incubator for 42 h.
MTT VIABILITY ASSAY
Following the 42 hour post-exposure incubation period: MTT test (MTT Loading/Formazan Extraction) was performed and tissues were incubated for 3 h (± 5 minutes) at 37 °C, 5 % CO2 in a humidified incubator.
OPTICAL DENSITY MEASUREMENTS
At the end of the formazan extraction period: The optical density was measured at 570 nm using a plate reader. - Irritation / corrosion parameter:
- % tissue viability
- Value:
- 79.55
- Positive controls validity:
- valid
- Remarks:
- Viability: 1.36%
- Irritant / corrosive response data:
Following a 42 minutes exposure and 42 h of recovery period, the relative mean viability of the tissues treated with the test item was 79.55 % with a Variation coefficient of 3.49 as assessed by the MTT assay.- Other effects:
- None
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the test conditions, "OF14 AT" was concluded to be NON IRRITANT.
- Executive summary:
The test substance "OF14 AT" was subjected to skin irritation assay, conducted according to OECD 439 (2015).
The test was carried out using reconstructed human epidermis (RHE), in triplicate. The exposure of the insert to the test susbtance was carried out for 42 minutes at room temperature.
After treatment the inserts were rinsed with D-PBS and post-incubated with growth medium for additional 42 hours at 37 +/- 1°C and 5 +/-1% CO2. Finally, inserts were incubated with MTT solution in order to evaluate cell viability which is a direct measure of the irritant potential of the test substance.
Under these conditions, the test substance "OF 14 AT" was concluded to be non-irritant.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2007
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Remarks:
- Study performed according to French offical method published in December 1999 in National register N° 302. No deviation has been reported. No Eye irritation classification can be made, only based on this cytotoxic experiment.
- Qualifier:
- according to guideline
- Guideline:
- other: Appendix VI of the French National Register N°302 of December, 1999
- Principles of method if other than guideline:
- The method is an alternative to animal experimentation, to determine the ocular irritant potential of cosmetic products. The principle is based on assessing the cytotoxicity of the product tested by identifying the concentration causing 50% mortality (IC50) using the technique of neutral red release.
- GLP compliance:
- yes
- Species:
- rabbit
- Strain:
- other: Rabbit cornea fibroblasts: SIRC line (ATCC CCL60)
- Details on test animals or tissues and environmental conditions:
- no animal test
Rabbit cornea fibroblasts: SIRC line from ATCC Cat N°2-552 - CCL60 - Vehicle:
- unchanged (no vehicle)
- Controls:
- not required
- Amount / concentration applied:
- Dilution at 5%, 15%, 25%, 35% and 50% of the test material are used.
- Duration of treatment / exposure:
- Cells are exposed 1 minute to the dilution of the test material
- Observation period (in vivo):
- not specified
- Number of animals or in vitro replicates:
- Dilution at 5%, 15%, 25%, 35% were tested in Monoplicate, Dilution 50% was tested in duplicate
- Details on study design:
- Positive and negative control are used.
A suspension at 200,000 cells/ ml complete DMEM medium is prepared 24 hours before the assay is performed.
The day of the experiment, 1 ml of the solution of neutral red at 0.05mg/ml, is deposited on the cells, and placed for 3 hours in the incubator.
Then cells are exposed to a dilution of the test substance for 1 minute. Every dilution is tested one time except the dilution 50% which is tested in duplicate.
After exposure, cells are washed with 1 ml of PBS, and are treated with a revelatory solution (acetic acid/ Ethanol :1/100) .
The optical density of the resulting solution is measured at 540 nm.
The optical density (OD) values obtained for each test chemical are then used to calculate cell viability. The relative cell viability is expressed as a percentage and obtained by dividing the OD of test chemical by the OD of the solvent control.
The following formula is used: % mortality = 100- (OD cells exposed to test mateiral)/ (OD of negative control) X 100.
The curve of per cent cell mortality vs. Concentration of the product is plotted. the IC50 of the test product is obtained by extrapolation from the dose response curve. - Irritation parameter:
- other: Percentage of mortalité observed at the 50% dilution
- Value:
- 31
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- not specified
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Remarks:
- 31% of mortality observed at the 50% dilution
- Irritation parameter:
- other: Estimated IC 50 (%)
- Value:
- > 50
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- not specified
- Positive controls validity:
- valid
- Irritant / corrosive response data:
- The cytotoxicity of tested material is slightly important.
IC 50 is greater to 50% and the percentage of mortality observed at the dilution 50% is 31% - Interpretation of results:
- other:
- Remarks:
- table of French national register N°302, December 1999
- Conclusions:
- The test material is considered as slightly irritant considering the fact that the cytotoxicity is not very important according to guideline followed
- Executive summary:
An in vitro eye irritation study was performed, on rabbit cornea fibroblasts, according to French national Method published in December 1999 in National register N° 302.
The principle of the method is based on assessing the cytotoxicity of the product tested by identifying the concentration causing 50% mortality (IC50) using the technique of neutral red release.
The IC50 was up to 50% and the percentage of mortality at the dilution 50% is 31% .
According to the method the cytotoxicity is considered not very important.
The cytotoxicity is slightly important according to guideline followed.
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- October- November 2015
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Remarks:
- Internal laboratory guidelines
- Principles of method if other than guideline:
- The method is designed to evaluate the biological response of mammalian cells in vitro, by assessment of cell viability after exposure to the test substance.
- GLP compliance:
- yes
- Irritation parameter:
- other:
- Value:
- > 102.75
- Interpretation of results:
- other: the IC50 of the test item resulted to be 102.75 mg/mL
- Conclusions:
- Under the test condition applied, the IC50 of the test item "OF14 AT", resulted to be 102.75 mg/mL: this means that at concentrations of the test substance higher than 102.75 mg/mL the cytotoxicity will increase (>50% of cell mortality), while at lower concentrations cytotoxicity will decrease (< 50% of cell mortality).
- Executive summary:
The cytotoxicty test was carried out by applying the direct contact method on 8 concentrations of the test substance. The dilutions of the substance, were applied in 6 replicas on BALB-3T3 cells for 24 hours at 37°C. Cytotoxicity was qualitatively evaluated by microscopy and quantitatively by neutral red uptake (NRU) assay. The NRU assay allows the quantitative determination of cytotoxicity expressed as IC 50 value (inhibitory concentration estimated to affect the endpoint by 50%).
Under the test condition applied, the IC50 of the test item "OF14 AT", resulted to be 102.75 mg/ml: this means that at concentrations of the test substance higher than 102.75 mg/mL the cytotoxicity will increase (>50% of cell mortality), while at lower concentrations cytotoxicity will decrease (< 50% of cell mortality). In details, 4 concentrations of the test substance (C5: 64.247 mg/mL, C6: 43.705 mg/mL, C7: 29.732 mg/ml and C8: 20.226 mg/mL) resulted to be non-toxic, as their relative cell viability was superior or equal to 70% of the control group (see ISO 10993 -5:2009, par A.2.4).
Referenceopen allclose all
Table 1: Optical density means for the test material and percentage of cells mortality
Optical density (OD) and cells mortality (%) |
||||||
Test material concentration % (p/p) |
0 |
5 |
10 |
25 |
35 |
50 |
OD Well 1 |
1.319 |
1.035 |
0.937 |
0.928 |
0.902 |
0.843 |
OD Well 1 |
1.380 |
1.028 |
0.934 |
0.930 |
0.903 |
0.856 |
OD means Well 1 |
1.350 |
1.032 |
0.936 |
0.929 |
0.903 |
0.850 |
OD Well 2 |
1.059 |
|
|
|
|
0.829 |
OD Well 2 |
1.064 |
|
|
|
|
0.822 |
OD means Well 2 |
1.062 |
|
|
|
|
0.826 |
OD means |
1.206 |
1.032 |
0.936 |
0.929 |
0.903 |
0.838 |
% mortality |
0 |
14 |
22 |
23 |
25 |
31 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
In an in vitro eye irritation study Cohesium was found to be only slightly cytotoxic. In an OECD 439 study, OF 14 AT was found to be non-irritant. OF14 AT was tested for cytotoxicity in a GLP study, and the IC50 resulted to be 102.75 mg/mL.
Also, considering the nature of the main constituents of the registered substance (oligo/polysaccharides and the corresponding monomers), the test item does not need to be classified as irritating for eyes and skin under CLP Regulation (1272/2008 CE).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.